Literature DB >> 426679

Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group.

.   

Abstract

The Diabetic Retinopathy Study (DRS) Research Group has so far identified four retinopathy factors that increase the two-year risk of developing severe visual loss. The risk grows as the number of risk factors increases. Eyes with three or more risk factors (eyes with "high-risk characteristics") are at a much higher risk than eyes with two or fewer factors. The DRS protocol was changed in 1976 to require consideration of treatment for these "high-risk" eyes.

Entities:  

Mesh:

Year:  1979        PMID: 426679     DOI: 10.1001/archopht.1979.01020010310003

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  37 in total

1.  Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Authors:  André Messias; José Afonso Ramos Filho; Katharina Messias; Felipe P P Almeida; Rogério A Costa; Ingrid U Scott; Florian Gekeler; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

2.  Diabetic retinopathy: clinical findings and management.

Authors:  K Viswanath; D D Murray McGavin
Journal:  Community Eye Health       Date:  2003

3.  Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.

Authors:  M M K Muqit; G R Marcellino; D B Henson; L B Young; G S Turner; P E Stanga
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

4.  The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.

Authors:  E C Wade; G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.

Authors:  Mary Gilbert Lawrence
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 6.  Does pregnancy accelerate the rate of progression of diabetic retinopathy?

Authors:  Bhavna P Sheth
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

7.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

8.  Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.

Authors:  Chang-Sue Yang; Kuo-Che Hung; Yi-Ming Huang; Wen-Ming Hsu
Journal:  J Ocul Pharmacol Ther       Date:  2013-03-15       Impact factor: 2.671

9.  Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group.

Authors: 
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

10.  Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization.

Authors:  Dimple Modi; Paulpoj Chiranand; Levent Akduman
Journal:  Clin Ophthalmol       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.